[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100575491":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":36,"locations":42,"responsibleParty":64,"collaborators":67,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":72,"sex":78,"minAge":79,"maxAge":80,"enrollmentInfo":81,"targetDuration":26,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":91,"overallStatus":95,"whyStopped":26,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"Nawaz Sharif Medical College","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ginger Group","EXPERIMENTAL","Ginger",[13],"Dietary Supplement: Ginger",{"label":15,"type":16,"description":17,"interventionNames":18},"Doxylamine Group","ACTIVE_COMPARATOR","Tab. Doxylamine Succinate USP",[19],"Drug: Doxylamine Succinate USP",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Doxylamine Succinate USP","Tab. Doxylamine Succinate",[15],null,{"type":28,"name":11,"description":29,"armGroupLabels":30,"otherNames":26},"DIETARY_SUPPLEMENT","Ginger (zingiber officinale)",[9],[32],{"name":33,"affiliation":34,"role":35},"Syeda Shaista Waheed Professor, MBBS, FCPS","Nawaz Sharif Medical College, Gujrat","STUDY_DIRECTOR",[37],{"name":38,"role":39,"phone":40,"phoneExt":26,"email":41},"Zunnaira Pervaiz Pervaiz, MBBS","CONTACT","+923364209554","zunairapervaiz.zp@gmail.com",[43],{"facility":44,"status":26,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Aziz Bhatti Shaheed Teaching Hospital","Gujrat","Punjab Province","50700","Pakistan","PK",{"type":51,"coordinates":52},"Point",[53,54],74.07542,32.5742,{"lat":54,"lon":53},[57,61],{"name":58,"role":39,"phone":59,"phoneExt":26,"email":60},"Syed Muhammad Ali Shah, MBBS, FCPS","03336066295","syedmuhammadalishah5@gmail.com",{"name":62,"role":63,"phone":26,"phoneExt":26,"email":26},"Zunnaira Pervaiz PGR, MBBS, MS Gynae and Obs","PRINCIPAL_INVESTIGATOR",{"type":63,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Zunaira Pervez","Post Gradute Resident",[68],{"name":69,"class":6},"University of Gujrat","100575491","tablet-ginger-versus-tablet-doxylamine-succinate-in-control-of-nausea-and-vomiting-in-pregnancy-100575491",false,"NCT06772974","Tablet Ginger Versus Tablet Doxylamine Succinate in Control of Nausea and Vomiting in Pregnancy","Comparison of Tablet Ginger Versus Tablet Doxylamine Succinate in Control of Nausea and Vomiting in Pregnancy","GDNVP","Inclusion Criteria:\n\n* Pregnant women age\\>18 years\n* 5 to 8weeks of gestation and 8+1to11weeks\n* Attending OPD with signs and symptoms of nausea and vomiting with ultrasound confirmed pregnancy\n* 1st and 2nd gravida\n* Patients who will give consent\n\nExclusion Criteria:\n\n* Patients were hospitalized for Hyperemesis Gravidarum\n* Medical disorders like Diabetes Mellitus, Hepatic, Gastric, Pancreatic, Pyelonephritis, Thyroid and Psychological Disorder\n* Patients not responding to treatment after 1week will be excluded\n* Patients who will not give consent","FEMALE","18 Years","49 Years",{"count":82,"type":83},66,"ESTIMATED","INTERVENTIONAL",[86],"NA","Nausea and vomiting are common GI symptoms of pregnancy. Multiple managing options have been used for NVP. Doxylamine succinate is used as first line treatment for NVP despite that alternative modalities such as ginger extracts and tablets is being explored.\n\nThis RCT will be conducted after taking ethical approval and informed consent, in Department of Gynecology, Aziz Bhatti Shaheed teaching hospital, Gujrat. Patients will be divided into two equal groups. One group will receive tablet ginger while other group will receive Doxylamine succinate tablets. Baseline PUQE score (3- 15 point scale) over 24 hour will be noted according to symptoms of nausea and vomiting following 7 days of treatment and then at 2nd and 3rd week. Comparison of the change in the severity of nausea from baseline scores (Post-therapy PUQE score - base line scores) in both groups will be considered for results.",[89,90],"Nausea Gravidarum","Hyperemesis Gravidarum",[92,93,94],"Nausea","Vomiting","Pregnancy","NOT_YET_RECRUITING","2025-01-15",{"date":98,"type":99},"2025-01-17","ACTUAL",{"date":96,"type":83},{"date":102,"type":83},"2025-07-15",{"name":5,"class":6},1]